Neuropsychological Testing Using Mobile Devices

This study has been withdrawn prior to enrollment.
(no subjects agreed to participate)
Sponsor:
Information provided by (Responsible Party):
Englewood Hospital and Medical Center
ClinicalTrials.gov Identifier:
NCT01776086
First received: January 23, 2013
Last updated: July 9, 2013
Last verified: July 2013
  Purpose

The purpose of this studying is to develop and characterize neuropsychological testing software for evaluating the prefrontal and temporal function of patients. As no software has been used for this purpose, this study will gather pilot data on the baseline performance of patients in a hospital setting that lack any neurological impairment. After creating this baseline, later experiments can be proposed to compare the performance in normal subjects with those who have neurologic injury or disease.


Condition Intervention
Inpatients With Normal Neurological Function
Behavioral: Neurological testing

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Neuropsychological Testing Using Mobile Devices

Further study details as provided by Englewood Hospital and Medical Center:

Primary Outcome Measures:
  • Determination of "normal performance" curve [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    The purpose of this study is to generate a curve of "normal performance" on the neurological test for hospitalized patients of different ages


Enrollment: 0
Study Start Date: January 2013
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Normal patients
for patients with normal score on neurological testing with Folstein Mini-Mental Status Exam will then take the Scenes Task
Behavioral: Neurological testing
Other Names:
  • Scenes Task
  • Folstein Mini-Mental Status Exam

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Inpatients > = 18 years of age
  • Patient must be able to provide informed consent

Exclusion Criteria:

  • Patients with score of < 26 on Folstein Mini-Mental Status Exam
  • Patients with known brain lesions
  • Patients with history of stroke, neurologic disease or dementia
  • Patients with acute illness or who are in imminent distress
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01776086

Locations
United States, New Jersey
Englewood Hospital and Medical Center
Englewood, New Jersey, United States, 07631
Sponsors and Collaborators
Englewood Hospital and Medical Center
Investigators
Principal Investigator: James Young, MD, PhD Englewood Hospital and Medical Center
  More Information

No publications provided

Responsible Party: Englewood Hospital and Medical Center
ClinicalTrials.gov Identifier: NCT01776086     History of Changes
Other Study ID Numbers: E-12-471
Study First Received: January 23, 2013
Last Updated: July 9, 2013
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on July 22, 2014